| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
|
N Engl J Med
|
2006
|
10.95
|
|
2
|
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.
|
Arthritis Rheum
|
2008
|
4.02
|
|
3
|
Thiazolidinedione use and bone loss in older diabetic adults.
|
J Clin Endocrinol Metab
|
2006
|
3.15
|
|
4
|
Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass.
|
Nat Med
|
2012
|
2.80
|
|
5
|
Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand.
|
Arthritis Rheum
|
2009
|
2.47
|
|
6
|
The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial.
|
Arthritis Rheum
|
2008
|
2.37
|
|
7
|
A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22.
|
Arthritis Rheum
|
2010
|
2.02
|
|
8
|
Wntless functions in mature osteoblasts to regulate bone mass.
|
Proc Natl Acad Sci U S A
|
2012
|
1.85
|
|
9
|
Targeted deletion of Sost distal enhancer increases bone formation and bone mass.
|
Proc Natl Acad Sci U S A
|
2012
|
1.78
|
|
10
|
Acid-suppressive medications and risk of bone loss and fracture in older adults.
|
Calcif Tissue Int
|
2008
|
1.71
|
|
11
|
The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids.
|
Arthritis Rheum
|
2007
|
1.65
|
|
12
|
Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk.
|
Ann Am Thorac Soc
|
2015
|
1.54
|
|
13
|
The signaling adapter protein DAP12 regulates multinucleation during osteoclast development.
|
J Bone Miner Res
|
2003
|
1.52
|
|
14
|
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT.
|
Ann Rheum Dis
|
2010
|
1.51
|
|
15
|
Patellar cartilage: T2 values and morphologic abnormalities at 3.0-T MR imaging in relation to physical activity in asymptomatic subjects from the osteoarthritis initiative.
|
Radiology
|
2009
|
1.47
|
|
16
|
The longterm outcome of osteoarthritis: rates and predictors of joint space narrowing in symptomatic patients with knee osteoarthritis.
|
J Rheumatol
|
2002
|
1.38
|
|
17
|
Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice.
|
Arthritis Rheum
|
2008
|
1.36
|
|
18
|
Very low prevalence of hip osteoarthritis among Chinese elderly in Beijing, China, compared with whites in the United States: the Beijing osteoarthritis study.
|
Arthritis Rheum
|
2002
|
1.36
|
|
19
|
The effects of impaired joint position sense on the development and progression of pain and structural damage in knee osteoarthritis.
|
Arthritis Rheum
|
2009
|
1.33
|
|
20
|
Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization.
|
Arthritis Rheum
|
2008
|
1.33
|
|
21
|
Glucocorticoid-induced autophagy in osteocytes.
|
J Bone Miner Res
|
2010
|
1.29
|
|
22
|
Association of statin use and development and progression of hip osteoarthritis in elderly women.
|
J Rheumatol
|
2005
|
1.25
|
|
23
|
Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity.
|
J Bone Miner Res
|
2004
|
1.22
|
|
24
|
Patterns of compartment involvement in tibiofemoral osteoarthritis in men and women and in whites and African Americans.
|
Arthritis Care Res (Hoboken)
|
2012
|
1.20
|
|
25
|
Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.
|
J Bone Miner Res
|
2010
|
1.19
|
|
26
|
Relationship between joint shape and the development of osteoarthritis.
|
Curr Opin Rheumatol
|
2010
|
1.17
|
|
27
|
Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women.
|
J Clin Endocrinol Metab
|
2009
|
1.16
|
|
28
|
Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates.
|
Ann Rheum Dis
|
2009
|
1.15
|
|
29
|
Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study.
|
J Clin Endocrinol Metab
|
2009
|
1.14
|
|
30
|
Lumbosacral transitional vertebrae: association with low back pain.
|
Radiology
|
2012
|
1.14
|
|
31
|
Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men.
|
J Clin Endocrinol Metab
|
2010
|
1.11
|
|
32
|
Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34).
|
J Clin Endocrinol Metab
|
2004
|
1.09
|
|
33
|
IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass.
|
J Immunol
|
2011
|
1.08
|
|
34
|
Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study.
|
J Am Geriatr Soc
|
2010
|
1.07
|
|
35
|
Reversing bone loss by directing mesenchymal stem cells to bone.
|
Stem Cells
|
2013
|
1.06
|
|
36
|
Glucocorticoid dose determines osteocyte cell fate.
|
FASEB J
|
2011
|
1.06
|
|
37
|
Variant alleles of the Wnt antagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis.
|
Arthritis Rheum
|
2012
|
1.05
|
|
38
|
Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naive postmenopausal women.
|
Osteoporos Int
|
2004
|
1.05
|
|
39
|
Role of bone architecture and anatomy in osteoarthritis.
|
Bone
|
2012
|
1.03
|
|
40
|
Defining incident radiographic hip osteoarthritis for epidemiologic studies in women.
|
Arthritis Rheum
|
2009
|
1.02
|
|
41
|
The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength.
|
Bone
|
2007
|
1.02
|
|
42
|
Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats.
|
Osteoporos Int
|
2005
|
1.02
|
|
43
|
To Wnt or not to Wnt: the bone and joint health dilemma.
|
Nat Rev Rheumatol
|
2013
|
1.01
|
|
44
|
Control of arthritis pain with anti-nerve-growth factor: risk and benefit.
|
Curr Rheumatol Rep
|
2012
|
0.99
|
|
45
|
The multiple facets of glucocorticoid action in rheumatoid arthritis.
|
Nat Rev Rheumatol
|
2012
|
0.99
|
|
46
|
Vanin-1 pantetheinase drives increased chondrogenic potential of mesenchymal precursors in ank/ank mice.
|
Am J Pathol
|
2008
|
0.98
|
|
47
|
Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
|
J Bone Miner Res
|
2009
|
0.98
|
|
48
|
Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency.
|
PLoS One
|
2007
|
0.98
|
|
49
|
Kyphosis and decline in physical function over 15 years in older community-dwelling women: the Study of Osteoporotic Fractures.
|
J Gerontol A Biol Sci Med Sci
|
2013
|
0.98
|
|
50
|
Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective.
|
Nat Clin Pract Rheumatol
|
2008
|
0.97
|
|
51
|
Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats.
|
Bone
|
2009
|
0.96
|
|
52
|
Consistency of knee pain and risk of knee replacement: the Multicenter Osteoarthritis Study.
|
J Rheumatol
|
2011
|
0.96
|
|
53
|
Osteoarthritis, bone mass, and fractures: how are they related?
|
Arthritis Rheum
|
2002
|
0.96
|
|
54
|
Effects of inflammation on bone: an update.
|
Curr Opin Rheumatol
|
2011
|
0.92
|
|
55
|
Risk factors for incident osteoarthritis of the hip and knee.
|
Curr Rev Musculoskelet Med
|
2011
|
0.92
|
|
56
|
Femoroacetabular Impingement: Prevalent and Often Asymptomatic in Older Men: The Osteoporotic Fractures in Men Study.
|
Clin Orthop Relat Res
|
2015
|
0.92
|
|
57
|
Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders.
|
Am J Med
|
2012
|
0.92
|
|
58
|
Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice.
|
PLoS One
|
2010
|
0.92
|
|
59
|
Active shape modeling of the hip in the prediction of incident hip fracture.
|
J Bone Miner Res
|
2011
|
0.92
|
|
60
|
Association of incident symptomatic hip osteoarthritis with differences in hip shape by active shape modeling: the Johnston County Osteoarthritis Project.
|
Arthritis Care Res (Hoboken)
|
2014
|
0.90
|
|
61
|
Changes in serum fibroblast growth factor 2 in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34).
|
Osteoporos Int
|
2005
|
0.89
|
|
62
|
Glucocorticoid-induced osteoporosis.
|
Curr Osteoporos Rep
|
2009
|
0.89
|
|
63
|
Effect of glucocorticoids on bone density.
|
Med Pediatr Oncol
|
2003
|
0.89
|
|
64
|
Self-reported weight at birth predicts measures of femoral size but not volumetric BMD in eldery men: MrOS.
|
J Bone Miner Res
|
2011
|
0.89
|
|
65
|
Kyphosis and paraspinal muscle composition in older men: a cross-sectional study for the Osteoporotic Fractures in Men (MrOS) research group.
|
BMC Musculoskelet Disord
|
2014
|
0.88
|
|
66
|
Medication-induced osteoporosis.
|
Curr Osteoporos Rep
|
2007
|
0.86
|
|
67
|
Radiographic methods in knee osteoarthritis: a further comparison of semiflexed (MTP), schuss-tunnel, and weight-bearing anteroposterior views for joint space narrowing and osteophytes.
|
J Rheumatol
|
2002
|
0.86
|
|
68
|
Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.
|
Bone
|
2006
|
0.85
|
|
69
|
Hand joint space narrowing and osteophytes are associated with magnetic resonance imaging-defined knee cartilage thickness and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative.
|
J Rheumatol
|
2011
|
0.85
|
|
70
|
Change in bone mineral density at one year following glucocorticoid withdrawal in kidney transplant recipients.
|
Clin Transplant
|
2010
|
0.85
|
|
71
|
Changes in plasma fibronectin isoform levels predict distinct clinical outcomes in critically ill patients.
|
Biomark Insights
|
2011
|
0.84
|
|
72
|
Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents.
|
J Bone Miner Res
|
2011
|
0.84
|
|
73
|
High hip fracture risk in men with severe aortic calcification: MrOS study.
|
J Bone Miner Res
|
2014
|
0.82
|
|
74
|
Are There Sex Differences in Knee Cartilage Composition and Walking Mechanics in Healthy and Osteoarthritis Populations?
|
Clin Orthop Relat Res
|
2015
|
0.82
|
|
75
|
Glucocorticoids and osteocyte autophagy.
|
Bone
|
2013
|
0.82
|
|
76
|
Targeting the Wnt signaling pathway to augment bone formation.
|
Curr Osteoporos Rep
|
2008
|
0.82
|
|
77
|
Diffuse idiopathic skeletal hyperostosis association with thoracic spine kyphosis: a cross-sectional study for the Health Aging and Body Composition Study.
|
Spine (Phila Pa 1976)
|
2014
|
0.82
|
|
78
|
The management of secondary osteoporosis.
|
Best Pract Res Clin Rheumatol
|
2005
|
0.81
|
|
79
|
Accuracy of self-reported diagnosis of hip replacement.
|
Arthritis Care Res (Hoboken)
|
2010
|
0.81
|
|
80
|
Frailty and hip osteoarthritis in men in the MrOS cohort.
|
J Gerontol A Biol Sci Med Sci
|
2013
|
0.81
|
|
81
|
Femoroacetabular impingement.
|
Arthritis Rheumatol
|
2015
|
0.80
|
|
82
|
Common genetic variation in the Estrogen Receptor Beta (ESR2) gene and osteoarthritis: results of a meta-analysis.
|
BMC Med Genet
|
2010
|
0.79
|
|
83
|
Parathyroid hormone update.
|
Rheum Dis Clin North Am
|
2006
|
0.79
|
|
84
|
Common mistakes in the clinical use of bone mineral density testing.
|
Nat Clin Pract Rheumatol
|
2008
|
0.78
|
|
85
|
Actigraphy- and Polysomnography-Measured Sleep Disturbances, Inflammation, and Mortality Among Older Men.
|
Psychosom Med
|
2016
|
0.78
|
|
86
|
Improved trabecular bone structure of 20-month-old male spontaneously hypertensive rats.
|
Calcif Tissue Int
|
2014
|
0.77
|
|
87
|
Global point signature for shape analysis of carpal bones.
|
Phys Med Biol
|
2014
|
0.76
|
|
88
|
β-Ecdysone Augments Peak Bone Mass in Mice of Both Sexes.
|
Clin Orthop Relat Res
|
2015
|
0.75
|
|
89
|
Editorial Comment: Symposium: Sex Differences in Musculoskeletal Disease and Science.
|
Clin Orthop Relat Res
|
2015
|
0.75
|
|
90
|
Hip pain while using lower extremity joints and sleep disturbances in elderly white women: results from a cross-sectional analysis.
|
Arthritis Care Res (Hoboken)
|
2012
|
0.75
|
|
91
|
Osteoporosis: yesterday, today and tomorrow.
|
Rheumatology (Oxford)
|
2011
|
0.75
|
|
92
|
Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat model.
|
Bone
|
2012
|
0.75
|